Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Shanu Modi, William Jacot, Toshinari Yamashita et al. · New England Journal of Medicine · 2022 · 2.3K citations · Full text

Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer

Francesco Schettini, Núria Chic, Fara Brasó‐Maristany et al. · npj Breast Cancer · 2021 · 655 citations · Full text

Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials

Carsten Denkert, Fenja Seither, Andreas Schneeweiß et al. · The Lancet Oncology · 2021 · 533 citations

Breast Oncology, Her2-low-positive Breast Cancer, Individual Patient Data +9

Evolution of HER2-low expression from primary to recurrent breast cancer

Federica Miglietta, Gaia Griguolo, Michele Bottosso et al. · npj Breast Cancer · 2021 · 211 citations · Full text

Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer

Paolo Tarantino, Qingchun Jin, Nabihah Tayob et al. · JAMA Oncology · 2022 · 199 citations · Full text